Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
Triumph Financial Inc
TFIN
$1.91B
| $88K | ﹤0.01% |
2,779
+2,370
| +579% | +$74.9K |
|
5252
First Financial Corp
THFF
$985M
| $88K | ﹤0.01% |
1,940
+1,432
| +282% | +$67.8K |
|
|
CHS
5253
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $88K | ﹤0.01% |
10,000
-81,300
| -89% | -$676K |
|
|
ISEE
5254
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $88K | ﹤0.01% |
28,407
-27,569
| -49% | -$77.5K |
|
5255
Aptevo Therapeutics
APVO
$5.1M
| – | – |
0
| – | – |
|
5256
PUT
Conduent
CNDT
$276M
| $87K | ﹤0.01% |
5,400
| – | – |
|
5257
iShares MSCI Singapore ETF
EWS
$1.06B
| $87K | ﹤0.01% |
3,360
| – | – |
|
5258
Hawkins
HWKN
$2.79B
| $87K | ﹤0.01% |
4,912
+3,668
| +295% | +$70.3K |
|
|
MITT
5259
TPG Mortgage Investment Trust
MITT
$227M
| $87K | ﹤0.01% |
1,514
+1,301
| +611% | +$75K |
|
5260
PUT
Nokia
NOK
$55.4B
| $87K | ﹤0.01% |
18,600
-14,900
| -44% | -$76.8K |
|
|
SPR
5261
PUT
DELISTED
Spirit AeroSystems
SPR
| $87K | ﹤0.01% |
1,000
| – | – |
|
5262
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$12.3M
| $87K | ﹤0.01% |
6,182
| – | – |
|
|
AAC
5263
DELISTED
AAC Holdings
AAC
| $87K | ﹤0.01% |
9,696
+8,439
| +671% | +$76.2K |
|
|
GCI
5264
PUT
DELISTED
Gannett Co., Inc
GCI
| $87K | ﹤0.01% |
7,500
+4,200
| +127% | +$43.9K |
|
|
CDTX
5265
DELISTED
Cidara Therapeutics
CDTX
| $86K | ﹤0.01% |
630
+160
| +34% | +$24.3K |
|
5266
Harmonic Inc
HLIT
$1.34B
| $86K | ﹤0.01% |
20,480
+18,549
| +961% | +$69.7K |
|
5267
CALL
Precigen
PGEN
$2.33B
| $86K | ﹤0.01% |
7,500
+7,000
| +1,400% | +$104K |
|
5268
PUT
Quanta Services
PWR
$104B
| $86K | ﹤0.01% |
2,200
-5,700
| -72% | -$214K |
|
5269
PUT
RadNet
RDNT
$5.44B
| $86K | ﹤0.01% |
8,500
+7,800
| +1,114% | +$81.3K |
|
5270
PUT
ProShares Ultra Semiconductors
USD
$2.82B
| $86K | ﹤0.01% |
33,600
+14,400
| +75% | +$36.3K |
|
5271
PUT
Zillow
ZG
$8.47B
| $86K | ﹤0.01% |
2,100
-2,000
| -49% | -$82.2K |
|
|
ANW
5272
DELISTED
Aegean Marine Petroleum Network
ANW
| $86K | ﹤0.01% |
19,940
+19,840
| +19,840% | +$83.7K |
|
|
BHVN
5273
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $86K | ﹤0.01% |
3,183
+1,741
| +121% | +$47.9K |
|
5274
CALL
MKS Inc
MKSI
$21.7B
| $85K | ﹤0.01% |
900
+600
| +200% | +$59.8K |
|
5275
Philips
PHG
$25.9B
| $85K | ﹤0.01% |
2,948
+2,155
| +272% | +$65K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.